Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Mental Retardation
|
March 8, 2003
Cost comparisons of community and institutional residential settings: historical review of selected research
Kevin K Walsh, Theodore A Kastner, Regina Gentlesk Green
Mental Retardation
|
February 1, 1994
Replication of a managed health care initiative for people with mental retardation living in the community
T Criscione, T A Kastner, D O'Brien, et al.
Neurology
|
May 1, 1996
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
P Damier, A Kastner, Y Agid, et al.
Brain Research
|
March 26, 1993
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease
A Kastner, E C Hirsch, Y Agid, et al.
Mental Retardation
|
October 1, 1993
Managed health care services for people with mental retardation: impact on inpatient utilization
T Criscione, T A Kastner, K K Walsh, et al.
Journal of Neurochemistry
|
May 23, 2000
Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse
A Kastner, E Moyse, S Bauer, et al.
American Journal of Public Health
|
January 1, 1990
AIDS and state developmental disability agencies: a national survey
A G Marchetti, R S Nathanson, T A Kastner, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
December 26, 2001
Cell cycle regulation during mouse olfactory neurogenesis
M E Legrier, A Ducray, A Propper, et al.
The International Journal of Developmental Biology
|
June 1, 1997
p34(cdc2) and mitotic cyclin expression in the developing quail neuroretina
X Espanel, A Kastner, O Stettler, et al.
Journal of Neurochemistry
|
September 1, 1993
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease
A Kastner, E C Hirsch, M T Herrero, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Mental Retardation
|
March 8, 2003
Cost comparisons of community and institutional residential settings: historical review of selected research
Kevin K Walsh, Theodore A Kastner, Regina Gentlesk Green
Mental Retardation
|
February 1, 1994
Replication of a managed health care initiative for people with mental retardation living in the community
T Criscione, T A Kastner, D O'Brien, et al.
Neurology
|
May 1, 1996
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
P Damier, A Kastner, Y Agid, et al.
Brain Research
|
March 26, 1993
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease
A Kastner, E C Hirsch, Y Agid, et al.
Mental Retardation
|
October 1, 1993
Managed health care services for people with mental retardation: impact on inpatient utilization
T Criscione, T A Kastner, K K Walsh, et al.
Journal of Neurochemistry
|
May 23, 2000
Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse
A Kastner, E Moyse, S Bauer, et al.
American Journal of Public Health
|
January 1, 1990
AIDS and state developmental disability agencies: a national survey
A G Marchetti, R S Nathanson, T A Kastner, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
December 26, 2001
Cell cycle regulation during mouse olfactory neurogenesis
M E Legrier, A Ducray, A Propper, et al.
The International Journal of Developmental Biology
|
June 1, 1997
p34(cdc2) and mitotic cyclin expression in the developing quail neuroretina
X Espanel, A Kastner, O Stettler, et al.
Journal of Neurochemistry
|
September 1, 1993
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease
A Kastner, E C Hirsch, M T Herrero, et al.
Page
of 8